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1. INTRODUCTION
SARS-CoV-2 originated in the Hubei province of China and 
quickly spread to several countries including Japan and South 
Korea [1]. The source of the infection was later traced back to the 
wet market in Wuhan, capital of Hubei [2]. A phylogenetic analysis 
of virus in Italy confirmed likely import of disease from China [3]. 
Rapid traveling modes such as air transport further accelerated the 
epidemic by introducing new cases into more countries [4]. As of 
April 13, 2020, there were 1,922,891 reported cases of SARS-CoV-2 
globally along with a huge death toll almost touching 120,000 [5]. 
There is increasing evidence that the virus may have jumped organ-
isms to reach humans through pangolins or similar animals acting 
as intermediates [6].
Emerging and re-emerging infections of this scale disrupt health 
system functioning and cause massive losses to the economy. 
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A B S T R AC T
Background: India was one of the countries to institute strict measures for Severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2) control in the early phase. Since, then, the epidemic growth trajectory was slow before registering an explosion 
of cases due to local cluster transmissions.
Methods: We estimated the growth rate and doubling time of SARS-CoV-2 for India and high burden states using crowdsourced 
time series data. Further, we also estimated the Basic Reproductive Number (R0) and Time-dependent Reproductive number 
(Rt) using serial intervals from the data. We compared the R0 estimated from five different methods and R0 from SB was 
further used in the analysis. We modified standard Susceptible-Infectious-Recovered (SIR) models to SIR/Death (SIRD) model 
to accommodate deaths using R0 with the sequential Bayesian method for simulation in SIRD models.
Results: On average, 2.8 individuals were infected by an index case. The mean serial interval was 3.9 days. The R0 estimated 
from different methods ranged from 1.43 to 1.85. The mean time to recovery was 14 ± 5.3 days. The daily epidemic growth 
rate of India was 0.16 [95% CI; 0.14, 0.17] with a doubling time of 4.30 days [95% CI; 3.96, 4.70]. From the SIRD model, it 
can be deduced that the peak of SARS-CoV-2 in India will be around mid-July to early August 2020 with around 12.5% of the 
population likely to be infected at the peak time.
Conclusion: The pattern of spread of SARS-CoV-2 in India is suggestive of community transmission. There is a need to increase 
funds for infectious disease research and epidemiologic studies. All the current gains may be reversed if air travel and social 
mixing resume rapidly. For the time being, these must be resumed only in a phased manner and should be back to normal levels 
only after we are prepared to deal with the disease with efficient tools like vaccines or medicine.
K E Y  P O I N T S
Question: What are the estimates of infectious disease parameters of early phase of novel SARS-CoV-2 epidemic in India?
Findings: Incidence pattern SARS-CoV-2 shows possible evidence of community transmission. However, the estimated Basic 
Reproductive Number (R0) is relatively lower than those observed in high burden regions (range 1.43–1.85). Our simulation 
using susceptible-infectious-recovered/death model shows that peak of SARS-CoV-2 in India is farther than currently projected 
and is likely to affect around 12.5% of population.
Meaning: The lower estimated R0 is indicative of the effectiveness of early social distancing measures and lockdown. Premature 
relaxation of the current control measures may result in large numbers of cases in India.
© 2020 The Authors. Published by Atlantis Press International B.V. 
This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).
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Mathematical modeling has been used widely to understand 
the spread of disease in populations [7]. One of the aims of the 
modeling is to estimate parameters that are critical to the spread 
of diseases such as basic reproductive number or Reproductive 
Number (R0) and incubation period [8]. This is quite useful in the 
scenario of the early spread of disease to plan future strategies.
India was one of the countries to institute strict measures for SARS-
CoV-2 control in the early phase [9]. The first case of SARS-CoV-2 
in India was reported on January 30 2020 from a student airlifted 
from Wuhan and at the same time another 800 suspected individ-
uals kept under observation [10]. Since then, the epidemic growth 
trajectory was slow before registering an explosion of cases due to 
local cluster transmissions. In this paper, we describe the current 
trend of SARS-CoV-2 transmission in India and estimate basic 
parameters such as basic reproductive number R0 and time repro-
ductive number Rt, doubling time and future trend for India from 
the real-world datasets. Our findings will help to understand the 
effectiveness of government response and recalibrate suppression 
strategies for the epidemic.
2. METHODOLOGY
We used crowdsourced time series data available from the internet 
to estimate country-specific parameters for the epidemic [11]. As 
of now, this is the best available database for information on SARS-
CoV-2 in India in the public domain. The most reliable information 
in this database is regarding the daily reported incidence of COVID 
cases. Also, it contains aggregated information on total confirmed 
cases, total death, and total recovery. We did not use variables with 
limited information. The data was scraped on to R software on 
12th April 2020, cleaned and reshaped for the current analysis [12]. 
Package ggplot2 was mainly used to create figures along with features 
from base R [13]. We defined serial interval as the time difference in 
diagnosis of SARS-CoV-2 in infectee and infector [14]. We assumed 
serial interval and generation time to be same. The growth rate was 
computed from this incidence curve by fitting a log-linear model [15] 
and the basic reproduction number (R0) was obtained from the previ-
ously calculated serial interval. We also calculated the time-dependent 
reproductive number (Rt) to show the change in infectivity over time. 
State-wise growth was measured using the slope from a linear model. 
To estimate an R0 for projection purposes, in addition, to Log-Linear 
(LL), we also estimated R0 from other methods such as Exponential 
Growth (EG), Maximum likelihood estimation (ML), and Sequential 
Bayesian (SB) Method and Estimation of time-dependent reproduc-
tion numbers (TD) [16]. We selected Sequential Bayesian (SB) Method 
to account for stochasticity in incidence curves as the priors change 
with time and are drawn from posterior distribution from time- 
dependent informative priors [16].
Conceptually, susceptible individuals become infectious (i.e., move 
from the susceptible compartment to the infectious compartment), 
and then ultimately recover from the infection (i.e., move from the 
infectious compartment to the recovered compartment). The rates at 
which they move from one compartment to another depending on 
the proportion of the population in each of these compartments, as 
well as the transmission and recovery rates associated with the disease. 
We modified standard SIR models to accommodate an additional 
compartment for deaths by assuming transition probabilities, the 
Susceptible-Infectious-Recovered/Death (SIRD) model. Our model 
can be represented by the following ordinary differential equation
Figure 1 | Daily and cumulative incidence of SARS-CoV-2 cases in India 

















where β is the disease transmission rate, γ is the recovery rate, α 
is the case fatality rate and ρ rate at which death occurs. β is the 
product of the contact rate and transmission probability. As these 
parameters could not be estimated directly from the data, we 
back-calculated β from R0 which was computed previously using 
the Sequential Bayesian method. γ was calculated from the infec-
tious period − (1/infectious period). Case fatality rate (α) can be 
defined as deaths out of confirmed cases. ρ was estimated as inverse 
of time to death. We did not have ρ from our data and hence used an 
estimated range of 2–8 weeks from the WHO report [17]. We used 
5 weeks as the value of ρ for our study. The values of the parameters 
are as follows: R0 = 1.85, b = 0.13, γ = 0.07, α = 0.035 and ρ = 0.028.
2.1. Ethics Approval
We used anonymized data available in the public domain for this 
analysis.
3. RESULTS
The first case of SARS-CoV-2 was reported in Kerala state. Since then 
as of 12 April 2020, there are 9212 confirmed cases, 248 deaths, and 
1226 recovered in India from SARS-CoV-2. Maharashtra reports the 
highest number of cases (1982) and northeastern states have the lowest 
reported cases. The trend of the epidemic is shown in Figure 1. The 
daily growth rate of India fitted from a log incidence overtime is 0.16 
[95% CI; 0.14, 0.17]. The doubling time for the epidemic is 4.30 days 
[95% CI; 3.96, 4.70]. The growth rate and doubling time for the five 
states with the highest-burden are given in Table 1 and the rates for 
the states with available data are given in Figure S3. Kerala, which had 
the highest number of cases have effectively contained the outbreak by 
prolonging the doubling time, 19.48 days [95% CI; 10.35, 164.60] and 
the present growth rate is 0.03 [95% CI; 0.004, 0.066].
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Figure 2 | Number of secondary cases resulting from contact with each 
index case.
Figure 3 | Basic reproductive number (R0) calculated from different 
estimation methods.
Table 1 | Growth rate and doubling curve from log-linear fit for five states 
with highest burden of SARS-CoV-2 in India
State Growth rate (95% CI) Doubling time in days  (95% CI)
Tamil Nadu 0.173 (0.13, 0.20) 4.00 (3.32, 5.03)
Delhi 0.145 (0.12, 0.17) 4.78 (4.05, 5.83)
Maharashtra 0.144 (0.12, 0.16) 4.81 (4.23, 5.58)
Rajasthan 0.131 (0.11, 0.15) 5.27 (4.61, 6.17)
Gujarat 0.119 (0.07, 0.17) 5.77 (4.13, 9.59)
methods provided similar estimates (R0 > 1.80). We chose the 
Sequential Bayesian method (SB) over others for modeling as it was 
similar to the time-dependent R0 estimate and due to its flexibility 
to accommodate changes in transmission dynamics by incorporat-
ing prior distributions (Figure 4).
4. DISCUSSION
We estimated several parameters of SARS-CoV-2 infection in India, 
from crowdsourced data, and used a minimal set of assumptions in our 
forecasts. Models are useful in identifying the transmission dynamics 
if parameter inputs are based on real-world data in the early phase of 
the epidemic. Social distancing and travel ban to reduce community 
transmission seems to have an impact on infection transmission.
There is an urgent need to estimate setting specific parameters 
for future planning. For instance, we did not have information 
on death rate and recovery rate and used estimates from pub-
lished studies in the SIRD model. We also could not compute the 
incubation period as the database contained information only on 
linked cases and their admissions. Studies have shown that this 
could be approximately 5–8 days [18,19]. Also, it is difficult to 
separate the serial interval time from generation time overlaps as 
The nature of the epidemic is changing as the transmission is now 
more prominent within local communities as opposed to imported 
cases from individuals with travel history from China, the Middle 
East, and Europe. The type of transmission for most cases was not 
available. However, those individuals whose source of infection is 
yet to be determined can be assumed to be of local origin as travel 
history of SARS-CoV-2 patients is well tracked and documented in 
India (Figure S2).
There were 145 index cases who were identified to have transmitted 
the disease. On average, 2.8 individuals were infected by an index 
case and the range varied from 1 to 20 individuals. The number of 
secondary cases arising from exposure to primary cases (colored 
bubbles) and index cases are given with their unique identifiers 
(x-axis) (Figure 2). We had information on 413 pairs of primary 
and secondary cases to generate serial intervals for computing 
Basic Reproductive Number or R0. Serial interval ranged from 0 to 
19 days as the primary and secondary cases reported to the health 
facility on the same date. The mean of the serial interval was 3.9 
days with a standard deviation of 2.85 computed from a pair of 324 
pairs with non-zero values.
The lowest estimated R0 was from log-linear model 1.47 [95% CI; 
1.43, 1.51] and highest from time-dependent model 1.89 [95% CI; 
1.64–2.15] (Figure 3). The time-varying reproductive number (Rt) and 
SI distribution curve across the analysis time are provided in Figure S1. 
The recovery time was available only for 133 individuals. The mean 
time of recovery was 14 days (SD 5.3) ranging from 5 to 25 days.
From the compartmental models, it can be deduced that the peak 
of SARS-CoV-2 in India will be around mid-July to early August 
2020. Around 12.5% of the susceptible individuals are likely to be 
infected during the peak. The R0 estimated from different methods 
ranged from 1.43 in the log-linear method to 1.85 in exponential 
growth methods. Among the five models that were used for com-
puting R0: exponential, Time-dependent, and Sequential Bayesian 
Figure 4 | SIRD models based on R0 derived from Sequential Bayesian 
(SB) method.
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the information of cases is only available from reporting to the 
health authorities. Studies have suggested that SARS-CoV-2 can 
spread before the symptomatic phase which precludes a full under-
standing of the transmission pattern and underlying characteristics.
The R0 estimated across many studies may not reflect the actual 
transmission potential of the virus as these were measured in 
dynamic cohorts with some sort of mitigation measures. Estimates 
from studies among closed populations such as in Diamond 
Princess and Wuhan may be more reliable in this regard [20]. Riou 
et al. [21] estimated a reliable range for R0 which was between 1.4 
and 3.8 by simulating Wuhan epidemic incidence trajectories in 
a cluster environment. We estimated the range of R0 in India to 
be between 1.42 and 1.84 by comparing estimates from five dif-
ferent methods. Each of the R0 estimation methods employed in 
this analysis has its distinct advantages. The Time-dependent (TD) 
and Exponential growth methods are less prone to bias and over 
dispersion respectively. Furthermore, Sequential Bayesian uses 
prior information to update the estimates. Hence considering the 
similarity of R0 from all the above methods and the advantages 
provided by Bayesian updating of estimates from SB we decided to 
use it for SIRD modelling.
It can be therefore assumed that the real R0 in India is close to 1.85. 
The upper limit of the uncertainty of R0 in our analysis exceeds 
2 which may be indicative of the spread of infection at the local 
level and is comparable to the European scenario [22]. This is 
much lower than R0 in most countries and may be indicative of the 
effectiveness of measures taken at policy levels such as lockdown, 
cancellation of flights, social distancing, and sealing of identified 
hotspots.
India has done well to contain population-level spread to a great 
extent and to keep low mortality rates. India has one of the lowest 
attack rates of 0.47 at this stage of the epidemic which is several times 
lower than developed countries [23]. However, the epidemic is on 
the rise in India and creates new challenges such as optimal use of 
resources including swabs and testing kits besides identifying the 
high-risk groups. A recent study by Prem et al. [24] suggests that 
mitigation measures may be helpful only in delaying the infection 
from reaching its peak. Thus, it implies that the measures would 
likely prevent immediate flooding of hospitals preventing people 
from obtaining adequate care. The epidemic is yet to reach its peak in 
India which we expect to be around mid-July and early August. Our 
models suggest that 12.5% of the susceptible individuals are likely to 
be infected during the peak. This means that there are still around 
2–3 months to prepare for the worst phase of the epidemic.
Control measures of SARS-CoV-2 are less effective in populations 
with high density [20]. India has a huge population and the poten-
tial of SARS-CoV-2 for sustained transmission is well established 
[21,25]. We relied solely on estimates from the compartmental 
model which generates estimates from the infection parameters 
than depending on forecasts based on-trend. Our findings are 
based on simulations and further measures at policy level can alter 
the trajectory of the disease. Lipsitch et al. [26] recommends a 
strategy combining epidemiological studies, testing and lab studies 
as a more effective strategy in generating evidence for suppressing 
the epidemic.
Our analysis has certain limitations. First, there may be underreport-
ing of cases and a lack of validated data for research purposes avail-
able to the public. However, we compared the incidence from our 
dataset to the aggregated numbers elsewhere like European Disease 
Prevention and Control [23] and Worldometer [5] and the figures 
were similar. Another issue in estimating the parameters is the pres-
ence of super spreaders and asymptomatic cases. The estimated 
proportion of asymptomatic cases can be as high as 10% of the popu-
lation [27]. The virus can be spread around during the asymptomatic 
stage and delays from onset to reporting or treatment can be as high 
as 11 days [28]. Nonetheless, pooling estimates across several studies 
will aid in computing values that are closer to the true estimates.
In conclusion, our study provides information on India specific 
estimates of SARS-CoV-2 transmission parameters using real-
world data for the first time and shows that measures taken to date 
have been effective in reducing the spread of disease. However, the 
rising incidence and pattern of spread is suggestive of community 
transmission and is likely to increase cases in the future. The avail-
ability of individual-level data is critical to assess the effectiveness 
of ongoing measures and plan future strategies. There is a need to 
increasingly fund infectious disease research and epidemiologic 
studies and make that data available in the public domain. Future 
studies could focus on studying genetic variations in asymptomatic 
individuals and those index cases with higher disease transmis-
sion rates. There needs to be a renewed thinking of health systems 
particularly regarding emergency preparedness and optimal uti-
lization of scarce resources. Epidemiologists need to be consid-
ered in decision making and developing disease control strategies. 
Furthermore, there needs to be concerted action at the global level 
to contain the virus including joint research and developing vac-
cines and drugs. All the current gains may be reversed rapidly if air 
travel and social mixing resume rapidly. For the time being, these 
must be resumed only in a phased manner and should be back to 
normal levels only after we are prepared to deal with the disease 
with efficient tools like vaccines or medicine.
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